Medipharm Labs Corp Stock Analysis
MEDIF Stock | USD 0.05 0 3.85% |
Medipharm Labs Corp is overvalued with Real Value of 0.0426 and Hype Value of 0.05. The main objective of Medipharm Labs otc analysis is to determine its intrinsic value, which is an estimate of what Medipharm Labs Corp is worth, separate from its market price. There are two main types of Medipharm Labs' stock analysis: fundamental analysis and technical analysis.
The Medipharm Labs otc stock is traded in the USA on OTCQX Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Medipharm Labs' ongoing operational relationships across important fundamental and technical indicators.
Medipharm |
Medipharm OTC Stock Analysis Notes
The company has price-to-book ratio of 0.36. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medipharm Labs Corp recorded a loss per share of 0.14. The entity last dividend was issued on the 4th of October 2018. MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada. MEDIPHARM LABS is traded on OTC Exchange in the United States.The quote for Medipharm Labs Corp is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Medipharm Labs Corp contact David Pidduck at 705 719 7425 or learn more at https://www.medipharmlabs.com.Medipharm Labs Corp Investment Alerts
Medipharm Labs Corp has some characteristics of a very speculative penny stock | |
Medipharm Labs Corp had very high historical volatility over the last 90 days | |
The company reported the revenue of 21.71 M. Net Loss for the year was (54.8 M) with loss before overhead, payroll, taxes, and interest of (13.42 M). | |
Medipharm Labs Corp has accumulated about 21.99 M in cash with (13.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Medipharm Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.26 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medipharm Labs's market, we take the total number of its shares issued and multiply it by Medipharm Labs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Medipharm Profitablity
Medipharm Labs' profitability indicators refer to fundamental financial ratios that showcase Medipharm Labs' ability to generate income relative to its revenue or operating costs. If, let's say, Medipharm Labs is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Medipharm Labs' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Medipharm Labs' profitability requires more research than a typical breakdown of Medipharm Labs' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (2.07) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.61) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.61. Technical Drivers
As of the 24th of November, Medipharm Labs secures the Mean Deviation of 2.85, downside deviation of 4.49, and Risk Adjusted Performance of 0.0293. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medipharm Labs Corp, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Medipharm Labs, which can be compared to its peers in the industry. Please verify Medipharm Labs Corp coefficient of variation, maximum drawdown, skewness, as well as the relationship between the information ratio and downside variance to decide if Medipharm Labs Corp is priced some-what accurately, providing market reflects its recent price of 0.05 per share. As Medipharm Labs Corp appears to be a penny stock we also strongly suggest to check its total risk alpha numbers.Medipharm Labs Corp Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Medipharm Labs middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Medipharm Labs Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Medipharm Labs Outstanding Bonds
Medipharm Labs issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Medipharm Labs Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Medipharm bonds can be classified according to their maturity, which is the date when Medipharm Labs Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MGM Resorts International Corp BondUS552953CD18 | View | |
AerCap Global Aviation Corp BondUS00773HAA59 | View |
Medipharm Labs Predictive Daily Indicators
Medipharm Labs intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Medipharm Labs otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Medipharm Labs Forecast Models
Medipharm Labs' time-series forecasting models are one of many Medipharm Labs' otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Medipharm Labs' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Medipharm OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Medipharm Labs prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Medipharm shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Medipharm Labs. By using and applying Medipharm OTC Stock analysis, traders can create a robust methodology for identifying Medipharm entry and exit points for their positions.
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada. MEDIPHARM LABS is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Medipharm Labs to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
All Next | Launch Module |
Complementary Tools for Medipharm OTC Stock analysis
When running Medipharm Labs' price analysis, check to measure Medipharm Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medipharm Labs is operating at the current time. Most of Medipharm Labs' value examination focuses on studying past and present price action to predict the probability of Medipharm Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medipharm Labs' price. Additionally, you may evaluate how the addition of Medipharm Labs to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |